Sangamo Therapeutics
SGMO
SGMO
187 hedge funds and large institutions have $630M invested in Sangamo Therapeutics in 2019 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 65 increasing their positions, 54 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
14% less capital invested
Capital invested by funds: $729M → $630M (-$99M)
34% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 29
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
187
Holding in Top 10
–
Calls
$22.6M
Puts
$14.2M
Top Buyers
| 1 | +$21.6M | |
| 2 | +$13M | |
| 3 | +$12.4M | |
| 4 |
Renaissance Technologies
New York
|
+$8.64M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$7.51M |
Top Sellers
| 1 | -$13.6M | |
| 2 | -$10.9M | |
| 3 | -$8.18M | |
| 4 |
PCM
Peregrine Capital Management
Minneapolis,
Minnesota
|
-$6.98M |
| 5 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$5.74M |